IP Library Granted Patent US 9,193,820
Granted Patent B2
US 9,193,820 · App. 14/556,455 · Granted Nov 24, 2015

Antimicrobial polyurethane foam and process to make the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,193,820
App. No.
14/556,455
Granted
Nov 24, 2015
Kind
B2
Abstract

An antimicrobial polyurethane foam that is formed from: a multi-functional isocyanate component; an aqueous polyol component reactive with the multi-functional isocyanate component; an antimicrobial metallic compound; and a complexing agent. The complexing agent is used to form a stable blend of the antimicrobial metallic compound with the polyol component. Exemplary complexing agents include amine compounds, ammonium-containing compounds, and ammonia as well as combinations of these compounds. The antimicrobial metallic compound can be a silver, zinc, or copper compound. Desirably, the antimicrobial metallic compound is silver saccharinate. A process of making the antimicrobial polyurethane foam and stable blends used in the manufacture of the antimicrobial polyurethane foam are also disclosed.

Claims (12)

1. An antimicrobial polyurethane foam comprising a reaction product of:

a multi-functional isocyanate component;

an aqueous polyol component reactive with the multi-functional isocyanate component;

an antimicrobial metallic compound; and

a complexing agent, wherein the antimicrobial metallic compound and the complexing agent form a complex, wherein the complex is adapted to allow dissipation of the complexing agent such that the antimicrobial metallic compound is present as substantially the only antimicrobial metallic compound in the antimicrobial polyurethane foam, wherein the complexing agent is selected from amine compounds, ammonium-containing compounds and ammonia, further wherein the polyurethane foam comprises a flexible matrix of polyurethane material defining a plurality of open cells, wherein the antimicrobial metallic compound is uniformly distributed throughout the flexible matrix.

2. The antimicrobial polyurethane foam of claim 1 , wherein the antimicrobial metallic compound is a silver, zinc or copper compound.

3. The antimicrobial polyurethane foam of claim 1 , wherein the aqueous polyol component is selected from polyhydroxy-containing polyesters, polyoxyalkylene polyether polyols, polyhydroxyterminated polyurethane polymers, polyhydroxy-containing phosphorus compounds, and alkylene oxide adducts of polyhydric polythioesters, polyacetals, aliphatic polyols and thiols, and mixtures thereof.

4. The antimicrobial polyurethane foam of claim 1 , wherein the multi-functional isocyanate component is selected from the group consisting of toluene diisocyanate, monomeric methylene diisocyanate, polymeric methylene diisocyanate, and combinations thereof.

5. The antimicrobial polyurethane foam of claim 2 , wherein the antimicrobial metallic compound is selected from silver diazepine complexes, polymeric silver compounds, and silver compounds of saccharin.

6. The antimicrobial polyurethane foam of claim 5 , wherein the antimicrobial metallic compound is selected from silver saccharinate.

7. The antimicrobial polyurethane foam of claim 1 , further comprising a chain extender.

8. The antimicrobial polyurethane foam of claim 3 , wherein the aqueous polyol component is a polyether polyol.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jun 30, 2022
From: CITIBANK, N.A.
To: AVENT, INC.; AVANOS MEDICAL SALES, LLC
Reel/Frame 060557/0062 →
SECURITY INTEREST Recorded Jun 24, 2022
From: AVENT, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060441/0445 →
SECURITY INTEREST Recorded Jan 23, 2019
From: COOLSYSTEMS, INC.; AVENT, INC.
To: CITIBANK, N.A.
Reel/Frame 048117/0410 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2015
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: AVENT, INC.
Reel/Frame 034821/0150 →